A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment
Clinical trial NCT07324616 · COMPLETED
Trial details
- NCT number
- NCT07324616
- Sponsor
- Edgewise Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-26
- Primary completion
- 2026-04-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.